Skip to main content

Rut Mas deles Valls Cierco

Institutions of which they are part

Research technician
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Rut Mas deles Valls Cierco

Institutions of which they are part

Research technician
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Related news

The treatment with fremanezumab becomes the first approved therapy to demonstrate efficacy in children and adolescents, a key stage of life as it is one of the most disabling and concentrates the peak incidence of the disease.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.

Related professionals

Esteve Valverde, Enrique

Esteve Valverde, Enrique

Postdoctoral researcher
Systemic Diseases
Read more
de la Fuente Abelaira, Marisa

de la Fuente Abelaira, Marisa

Administration and Management
Research on Aging, Frailty and Transitions in Barcelona
Read more
Ariño  Rodríguez, Helena

Ariño Rodríguez, Helena

Postdoctoral researcher
Clinical Neuroimmunology
Read more
Camacho Arteaga, Lina Fernanda

Camacho Arteaga, Lina Fernanda

Research technician
Clinical Pharmacology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.